Sidney Atwood

1.9k total citations
27 papers, 904 citations indexed

About

Sidney Atwood is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Sidney Atwood has authored 27 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 16 papers in Epidemiology and 7 papers in General Health Professions. Recurrent topics in Sidney Atwood's work include Tuberculosis Research and Epidemiology (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Pneumonia and Respiratory Infections (5 papers). Sidney Atwood is often cited by papers focused on Tuberculosis Research and Epidemiology (14 papers), Pneumocystis jirovecii pneumonia detection and treatment (8 papers) and Pneumonia and Respiratory Infections (5 papers). Sidney Atwood collaborates with scholars based in United States, Peru and Russia. Sidney Atwood's co-authors include Thomas A. Gaziano, Garrett M. Fitzmaurice, J. Michael Gaziano, Molly F. Franke, Jaime Bayona, Carole D. Mitnick, Salmaan Keshavjee, Irina Gelmanova, Megan Murray and Mercedes C. Becerra and has published in prestigious journals such as The Lancet, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Sidney Atwood

26 papers receiving 867 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sidney Atwood United States 14 578 479 242 129 96 27 904
Gibril J. Njie United States 13 479 0.8× 382 0.8× 260 1.1× 181 1.4× 132 1.4× 21 971
Ferdinand W N M Wit Netherlands 22 1.4k 2.3× 550 1.1× 97 0.4× 209 1.6× 136 1.4× 43 2.1k
E. Jane Carter United States 13 430 0.7× 226 0.5× 123 0.5× 39 0.3× 88 0.9× 25 715
Meredith E. Clement United States 15 310 0.5× 368 0.8× 136 0.6× 72 0.6× 88 0.9× 55 871
Benson Njuguna Kenya 12 224 0.4× 161 0.3× 65 0.3× 71 0.6× 76 0.8× 23 567
John A. Sbarbaro United States 18 719 1.2× 565 1.2× 273 1.1× 175 1.4× 121 1.3× 67 1.3k
Maryam Mahmood United States 16 219 0.4× 336 0.7× 234 1.0× 152 1.2× 73 0.8× 56 871
Carmen Contreras United States 21 822 1.4× 652 1.4× 266 1.1× 22 0.2× 92 1.0× 90 1.2k
Christine U. Oramasionwu United States 15 264 0.5× 295 0.6× 42 0.2× 97 0.8× 112 1.2× 36 776
Baba Maiyaki Musa Nigeria 13 225 0.4× 350 0.7× 51 0.2× 33 0.3× 47 0.5× 57 831

Countries citing papers authored by Sidney Atwood

Since Specialization
Citations

This map shows the geographic impact of Sidney Atwood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sidney Atwood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sidney Atwood more than expected).

Fields of papers citing papers by Sidney Atwood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sidney Atwood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sidney Atwood. The network helps show where Sidney Atwood may publish in the future.

Co-authorship network of co-authors of Sidney Atwood

This figure shows the co-authorship network connecting the top 25 collaborators of Sidney Atwood. A scholar is included among the top collaborators of Sidney Atwood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sidney Atwood. Sidney Atwood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Atwood, Sidney, et al.. (2024). Beyond ‘‘Screen & Refer’’: Understanding Families’ Use of Resources for Health-Related Social Needs Identified via Primary Care. Academic Pediatrics. 24(8). 1314–1322. 2 indexed citations
3.
Trevisi, Letizia, et al.. (2020). Community Outreach for Navajo People Living with Diabetes: Who Benefits Most?. Preventing Chronic Disease. 17. E68–E68. 5 indexed citations
4.
Khan, Uzma, Helena Huerga, Aamir J. Khan, et al.. (2019). The endTB observational study protocol: treatment of MDR-TB with bedaquiline or delamanid containing regimens. BMC Infectious Diseases. 19(1). 733–733. 17 indexed citations
5.
Becerra, Mercedes C., Chuan-Chin Huang, Leonid Lecca, et al.. (2019). Transmissibility and potential for disease progression of drug resistantMycobacterium tuberculosis: prospective cohort study. BMJ. 367. l5894–l5894. 43 indexed citations
6.
King, Caroline, Sidney Atwood, Chris Brown, et al.. (2018). Identifying risk factors for 30-day readmission events among American Indian patients with diabetes in the Four Corners region of the southwest from 2009 to 2016. PLoS ONE. 13(8). e0195476–e0195476. 6 indexed citations
7.
King, Caroline, Sidney Atwood, Chris Brown, et al.. (2017). Primary care and survival among American Indian patients with diabetes in the Southwest United States: Evaluation of a cohort study at Gallup Indian Medical Center, 2009–2016. Primary care diabetes. 12(3). 212–217. 2 indexed citations
8.
Koenig, Serena P., Jessy G. Dévieux, Sidney Atwood, et al.. (2016). Trends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion of HIV Services in Haiti. PLoS ONE. 11(2). e0146903–e0146903. 16 indexed citations
9.
Khan, Faiz Ahmad, Irina Gelmanova, Molly F. Franke, et al.. (2016). Aggressive Regimens Reduce Risk of Recurrence After Successful Treatment of MDR-TB. Clinical Infectious Diseases. 63(2). 214–220. 13 indexed citations
10.
Velásquez, Gustavo E., J. Peter Cegielski, Megan Murray, et al.. (2015). Impact of HIV on mortality among patients treated for tuberculosis in Lima, Peru: a prospective cohort study. BMC Infectious Diseases. 16(1). 45–45. 5 indexed citations
11.
Riviere, Cynthia, Elizabeth Faust, Eduard J. Beck, et al.. (2014). Superior Outcomes and Lower Outpatient Costs With Scale-Up of Antiretroviral Therapy at the GHESKIO Clinic in Port-au-Prince, Haiti. JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(4). e72–e79. 2 indexed citations
12.
Seung, Kwonjune J., et al.. (2013). Salvage therapy for multidrug-resistant tuberculosis. Clinical Microbiology and Infection. 20(5). 441–446. 12 indexed citations
13.
Becerra, Mercedes C., Molly F. Franke, Sasha C. Appleton, et al.. (2012). Tuberculosis in Children Exposed at Home to Multidrug-resistant Tuberculosis. The Pediatric Infectious Disease Journal. 32(2). 115–119. 24 indexed citations
15.
Shin, Sonya, Salmaan Keshavjee, Irina Gelmanova, et al.. (2010). Development of Extensively Drug-resistant Tuberculosis during Multidrug-resistant Tuberculosis Treatment. American Journal of Respiratory and Critical Care Medicine. 182(3). 426–432. 76 indexed citations
16.
Franke, Molly F., Megan Murray, Maribel Muñoz, et al.. (2010). Food Insufficiency is a Risk Factor for Suboptimal Antiretroviral Therapy Adherence among HIV-Infected Adults in Urban Peru. AIDS and Behavior. 15(7). 1483–1489. 52 indexed citations
17.
Becerra, Mercedes C., Sasha C. Appleton, Molly F. Franke, et al.. (2010). Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study. The Lancet. 377(9760). 147–152. 102 indexed citations
18.
Keshavjee, Salmaan, Irina Gelmanova, Paul E. Farmer, et al.. (2008). Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. The Lancet. 372(9647). 1403–1409. 129 indexed citations
19.
Koenig, Serena P., Cynthia Riviere, Paul Leger, et al.. (2008). The cost of antiretroviral therapy in Haiti. Cost Effectiveness and Resource Allocation. 6(1). 3–3. 24 indexed citations
20.
Gaziano, Thomas A., et al.. (2008). Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. The Lancet. 371(9616). 923–931. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026